Need professional-grade analysis? Visit stockanalysis.com
$420.17B
64.06
20,238
N/A
Price Chart
Risk-Adjusted Performance
Jiangsu Hengrui Pharma Co Ltd (1276) Price Performance
Jiangsu Hengrui Pharma Co Ltd (1276) trades on Hong Kong Stock Exchange in HKD. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at HKD63.95, down 1.24% from the previous close.
Over the past year, 1276 has traded between a low of HKD53.70 and a high of HKD94.10. The stock has gained 16.0% over this period. It is currently 32.0% below its 52-week high.
Jiangsu Hengrui Pharma Co Ltd has a market capitalization of $420.17B, with a price-to-earnings ratio of 64.06.
About Jiangsu Hengrui Pharma Co Ltd
Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. It develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.
Company Info
- Sector
- Healthcare
- Exchange
- Hong Kong Stock Exchange
- Currency
- HKD
- Country
- Hong Kong
Financial Metrics
- Revenue (TTM)
- $27.98B
- EBITDA
- N/A
- Profit Margin
- 22.64%
- EPS (TTM)
- N/A
- Book Value
- 45519.86
Technical Indicators
- 52 Week High
- HK$95.20
- 52 Week Low
- HK$52.50
- 50 Day MA
- HK$69.47
- 200 Day MA
- HK$72.76
- Beta
- N/A
Valuation
- Trailing P/E
- 66.31
- Forward P/E
- N/A
- Price/Sales
- 14.87
- Price/Book
- 6.43
- Enterprise Value
- $378.68B